Erratum: Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice (Proceedings of the National Academy of Sciences of the United States of America (2015) 112:42 (13081-13086) DOI:10.1073/pnas.1407075112);Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 42, 2015, Pages 13081-13086

  Lee, Eun Kyung ^a,b   Joo, Eun Hye ^a,b   Song, Kyung A ^a,b   Choi, Bongkum ^b,c   Kim, Miyoung ^b,c   Kim, Seok Hyung ^a,b,c   Kim, Sung Joo ^a,b,c   Kang, Myung Soo ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Epstein Barr virus; Hodgkin's lymphoma; Humanized mice; Non Hodgkin's lymphoma; Reed sternberg cell

Indexed keywords

BUSULFAN; CD15 ANTIGEN; CD20 ANTIGEN; CD30 ANTIGEN; CD68 ANTIGEN; DELTA LIKE 1; EBER PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 2; KI 67 ANTIGEN; LATENT MEMBRANE PROTEIN; LATENT MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; NOTCH RECEPTOR; PROTEIN BCL 2; STAT6 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; CD34 SELECTION; CELL POPULATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; FETUS LIVER; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LARGE CELL LYMPHOMA; LYMPHOCYTE; MESENCHYMAL STEM CELL; MOUSE; NEWBORN; NONHODGKIN LYMPHOMA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REED STERNBERG CELL; SPLEEN CELL; T LYMPHOCYTE; UMBILICAL CORD BLOOD; VIRUS STRAIN; ANIMAL; B CELL LYMPHOMA; CLASSIFICATION; IMMUNOLOGY; NONOBESE DIABETIC MOUSE; PATHOGENICITY; SCID MOUSE; VIROLOGY;

ANIMALS; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOCYTES; LYMPHOMA, B-CELL; MICE; MICE, INBRED NOD; MICE, SCID;

EID: 84947475359     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.16052841134:27     Document Type: Erratum

References (53)

1. Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1(7335):702-703.
2. Epstein MA, Barr YM (1964) Cultivation in vitro of human lymphoblasts from Burkitt's malignant lymphoma. Lancet 1(7327):252-253.
3. Kieff ED, Rickinson AB (2007) Epstein-Barr virus and its replication. Fields Virology, eds Knipe DM, Howley PM (Lippincott Williams & Wilkins, Philadelphia), 5th Ed, Vol 2, pp 2603-2654.
4. Küppers R, Engert A, Hansmann ML (2012) Hodgkin lymphoma. J Clin Invest 122(10):3439-3447.
5. Glaser SL, et al. (1997) Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer 70(4):375-382.
6. Jarrett RF, et al.; Scotland and Newcastle Epidemiology of Hodgkin Disease Study Group (2005) Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study. Blood 106(7):2444-2451.
7. Zhang Y, et al. (2010) The prevalence of Epstein-Barr virus infection in different types and sites of lymphomas. Jpn J Infect Dis 63(2):132-135.
8. Zhou XG, Hamilton-Dutoit SJ, Yan QH, Pallesen G (1993) The association between Epstein-Barr virus and Chinese Hodgkin's disease. Int J Cancer 55(3):359-363.
9. Weiss LM, Movahed LA, Warnke RA, Sklar J (1989) Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 320(8):502-506.
10. Khan G, Coates PJ, Gupta RK, Kangro HO, Slavin G (1992) Presence of Epstein-Barr virus in Hodgkin's disease is not exclusive to Reed-Sternberg cells. Am J Pathol 140(4):757-762.
11. Kapatai G, Murray P (2007) Contribution of the Epstein-Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol 60(12):1342-1349.
12. Jarrett RF (2006) Viruses and lymphoma/leukaemia. J Pathol 208(2):176-186.
13. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337(8737):320-322.
14. Herbst H, et al. (1991) Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 88(11):4766-4770.
15. Izumi KM, et al. (1999) The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptorinteracting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation. Mol Cell Biol 19(8):5759-5767.
16. Sato K, et al. (2011) A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 117(21):5663-5673.
17. White RE, et al. (2012) EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest 122(4):1487-1502.
18. Yajima M, et al. (2008) A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis 198(5):673-682.
19. Yajima M, et al. (2009) T cell-mediated control of Epstein-Barr virus infection in humanized mice. J Infect Dis 200(10):1611-1615.
20. Ma SD, et al. (2011) A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol 85(1):165-177.
21. Ma SD, et al. (2012) An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol 86(15):7976-7987.
22. Imadome K, et al. (2011) Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells. PLoS Pathog 7(10):e1002326.
23. Kuwana Y, et al. (2011) Epstein-Barr virus induces erosive arthritis in humanized mice. PLoS One 6(10):e26630.
24. Islas-Ohlmayer M, et al. (2004) Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus. J Virol 78(24):13891-13900.
25. Atayar C, et al. (2007) Hodgkin's lymphoma associated T-cells exhibit a transcription factor profile consistent with distinct lymphoid compartments. J Clin Pathol 60(10):1092-1097.
26. Abdallah BM, et al. (2007) dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors. J Biol Chem 282(10):7339-7351.
27. Schmitt TM, Zúñiga-Pflücker JC (2002) Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17(6):749-756.
28. Hoffbrand AV, Pettit JE, Vya P (2010) Hodgkin's lymphoma. Color Atlas of Clinical Hematology, eds Hoffbrand AV, Pettit JE, Vya P (Mosby Elsevier Science, Philadelphia), Vol 1, pp 379-392.
29. Mani H, Jaffe ES (2009) Hodgkin lymphoma: An update on its biology with new insights into classification. Clin Lymphoma Myeloma 9(3):206-216.
30. Skinnider BF, et al. (2002) Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 99(2):618-626.
31. Kis LL, et al. (2011) STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma. Blood 117(1):165-174.
32. Harris NL, et al. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November 1997. J Clin Oncol 10(12):1419-1432.
33. Küppers R, Yahalom J, Josting A (2006) Advances in biology, diagnostics, and treatment of Hodgkin's disease. Biol Blood Marrow Transplant 12(1, Suppl 1):66-76.
34. Watanabe Y, et al. (2009) The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac (null) (NOG) mice (hu-HSC NOG mice). Int Immunol 21(7):843-858.
35. Lang J, et al. (2013) Studies of lymphocyte reconstitution in a humanized mouse model reveal a requirement of T cells for human B cell maturation. J Immunol 190(5):2090-2101.
36. Vuyyuru R, Patton J, Manser T (2011) Human immune system mice: Current potential and limitations for translational research on human antibody responses. Immunol Res 51(2-3):257-266.
37. Biswas S, et al. (2011) Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5+ B cells. Immunology 134(4):419-433.
38. Watanabe S, et al. (2007) Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 109(1):212-218.
39. Muñoz N, Davidson RJ, Witthoff B, Ericsson JE, De-Thé G (1978) Infectious mononucleosis and Hodgkin's disease. Int J Cancer 22(1):10-13.
40. Hjalgrim H, et al. (2000) Risk of Hodgkin's disease and other cancers after infectious mononucleosis. J Natl Cancer Inst 92(18):1522-1528.
41. Hjalgrim H, et al. (2003) Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 349(14):1324-1332.
42. Pfreundschuh M, et al. (1990) Detection of a soluble form of the CD30 antigen in sera of patients with lymphoma, adult T-cell leukemia and infectious mononucleosis. Int J Cancer 45(5):869-874.
43. Kurth J, et al. (2000) EBV-infected B cells in infectious mononucleosis: Viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13(4):485-495.
44. Kanzler H, Küppers R, Hansmann ML, Rajewsky K (1996) Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 184(4):1495-1505.
45. Scott PH, et al. (2001) Regulation of RNA polymerase III transcription during cell cycle entry. J Biol Chem 276(2):1005-1014.
46. Larminie CG, et al. (1997) Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J 16(8):2061-2071.
47. Ito M, et al. (2002) NOD/SCID/gamma (c) (null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 100(9):3175-3182.
48. Shultz LD, et al. (2005) Human lymphoid and myeloid cell development in NOD/LtSzscid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174(10):6477-6489.
49. in't Anker PS, et al. (2003) Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88(8):845-852.
50. Bartholomew A, et al. (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30(1):42-48.
51. Di Nicola M, et al. (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10):3838-3843.
52. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 75(3):389-397.
53. Raghunandan R, et al. (2008) Dlk1 influences differentiation and function of B lymphocytes. Stem Cells Dev 17(3):495-507.